Show simple item record

dc.contributor.authorKouijzer, IJE
dc.contributor.authorMulders-Manders, CM
dc.contributor.authorBleeker-Rovers, CP
dc.contributor.authorOyen, WJG
dc.date.accessioned2017-11-27T16:06:28Z
dc.date.issued2018-03
dc.identifier.citationSeminars in nuclear medicine, 2018, 48 (2), pp. 100 - 107
dc.identifier.issn0001-2998
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/955
dc.identifier.eissn1558-4623
dc.identifier.doi10.1053/j.semnuclmed.2017.11.004
dc.description.abstractFever of unknown origin (FUO) is commonly defined as fever higher than 38.3°C on several occasions during at least 3 weeks with uncertain diagnosis after a number of obligatory investigations. The differential diagnosis of FUO can be subdivided in four categories: infections, malignancies, noninfectious inflammatory diseases, and miscellaneous causes. In most cases of FUO, there is an uncommon presentation of a common disease. FDG-PET/CT is a sensitive diagnostic technique for the evaluation of FUO by facilitating anatomical localization of focally increased FDG uptake, thereby guiding further diagnostic tests to achieve a final diagnosis. FDG-PET/CT should become a routine procedure in the workup of FUO when diagnostic clues are absent. FDG-PET/CT appears to be a cost-effective routine imaging technique in FUO by avoiding unnecessary investigations and reducing the duration of hospitalization.
dc.formatPrint-Electronic
dc.format.extent100 - 107
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHumans
dc.subjectFever of Unknown Origin
dc.subjectFluorodeoxyglucose F18
dc.subjectC-Reactive Protein
dc.subjectAge Factors
dc.subjectCost-Benefit Analysis
dc.subjectPositron Emission Tomography Computed Tomography
dc.titleFever of Unknown Origin: the Value of FDG-PET/CT.
dc.typeJournal Article
dcterms.dateAccepted2017-11-23
rioxxterms.funderThe Institute of Cancer Research
rioxxterms.identifier.projectUnspecified
rioxxterms.versionofrecord10.1053/j.semnuclmed.2017.11.004
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2018-03
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfSeminars in nuclear medicine
pubs.issue2
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging
pubs.publication-statusPublished
pubs.volume48
pubs.embargo.termsNo embargo
icr.researchteamTranslational Molecular Imagingen_US
dc.contributor.icrauthorOyen, Willem


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0